Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis

Vikrant Ghatnatti1, Basavaraj Vastrad2, Swetha Patil3

  • 1Department of Endocrinology, J N Medical College, Belagavi and KLE Academy of Higher Education & Research 590010, Karnataka, India.

AIMS Neuroscience
|March 12, 2021
PubMed

Insights

This study identifies key genes and pathways involved in pituitary prolactinoma development using bioinformatics. Findings highlight potential molecular targets for understanding and treating this complex pituitary adenoma.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Bioinformatics

Background:

  • Pituitary prolactinoma is a complex and often fatal pituitary adenoma.
  • Understanding the molecular mechanisms driving prolactinoma initiation, progression, and metastasis is crucial.

Purpose of the Study:

  • To identify key genes and signaling pathways associated with pituitary prolactinoma using bioinformatics analysis.
  • To uncover potential molecular targets for improved understanding and treatment of pituitary prolactinoma.

Main Methods:

  • Downloaded and analyzed transcriptome microarray dataset GSE119063 from the Gene Expression Omnibus (GEO) database.
  • Utilized Limma package in R for differential gene expression (DEG) screening.
  • Performed pathway and Gene Ontology (GO) enrichment analyses.
  • Constructed and analyzed protein-protein interaction (PPI) networks, and gene-miRNA/TF regulatory networks using HIPPIE, NetworkAnalyst, and Cytoscape.
  • Validated hub genes using receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Identified 989 differentially expressed genes (DEGs), including 461 upregulated and 528 downregulated.
  • Pathway analysis revealed significant enrichment in retinoate biosynthesis II, stem cell pluripotency signaling, ALK2 signaling, vitamin D3 biosynthesis, cell cycle, and aurora B signaling.
  • GO analysis indicated enrichment in sensory organ morphogenesis, extracellular matrix, hormone activity, nuclear division, condensed chromosome, and microtubule binding.
  • Identified hub genes including SOX2, PRSS45, CLTC, PLK1, B4GALT6, RUNX1, GTSE1, LINC00598, SOX4, IRX1, and UNC13A.

Conclusions:

  • Integrated bioinformatics analysis successfully identified candidate genes and pathways implicated in pituitary prolactinoma.
  • These findings offer novel insights into the molecular mechanisms underlying pituitary prolactinoma.
  • The identified hub genes represent potential therapeutic targets for pituitary prolactinoma.

Related Concept Videos